MKI67 and adrenal cortex carcinoma: Given the significant DFS difference between early stages (1 + 2) and advanced ACC (p < 0.00001; Figure 1), and the low number of ACC cases, additional analyses were performed to evaluate the prognostic value for Ki-67 LI and CD8+ positive CTL between two extreme prognostic groups.